ESOT is building on the strengths of the TLJ 2018 experience (cross-fertilisation among different topic and field experts) to launch a completely new project, TLJ 2.0.
The concept of TLJ is LEARNING: learning never stops and emerging stars, expert professionals and opinion leaders need to keep learning to stay on top of their discipline. TLJ 2.0 provides value and produces concrete outcomes for all three of these types of transplantation professionals.
The meeting has a completely new structure now, that leads up to and beyond the face-to-face experience by introducing preparatory pre-meeting work to support consensus workgroups, and pre and post-meeting interaction and discussion among all participants.
Led by ESOT Sections, the TLJ 2.0 programme targets all audiences by including consensus workgroups, small mentoring sessions and keynote lectures, all connected seamlessly by ESOT’s innovative approach to meetings.
Workgroups will develop a series of consensus papers aimed for publications in Transplant International and further dissemination and interaction will be achieved by interactive materials hosted on Transplant Live, the ESOT e-learning platform.
Patients are welcome to attend and will be invited to contribute.
TLJ 2.0 is a comprehensive experience designed to promote discussion before and after the meeting.
WHO SHOULD ATTEND
The target audience for TLJ 2.0 includes all fields involved in health care and research with an affiliation in transplantation.
This includes but is not limited to:
Physicians from all fields with an involvement in transplantation
Researchers in emerging fields (stem cells, artificial organs, tissue and organ regeneration)
General surgeons and clinicians with an interest in transplantation
Nutrition and rehabilitation specialists and coordinators
Patients* (patients are welcome to attend the activities of the Learning workstream and will be invited to contribute to all consensus workstreams)
Maria Irene Bellini
Rotterdam, The Netherlands